Viewing Study NCT02999295


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-02-12 @ 11:50 PM
Study NCT ID: NCT02999295
Status: COMPLETED
Last Update Posted: 2019-08-21
First Post: 2016-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
Sponsor: National Cancer Center, Japan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module